Clinical Trial Search

Primary: To Evaluate the Effect of Oral Supplementation With Lactobacillus Reuteri on the Frequency of Confirmed UTI in Adult Women With Recurrent UTI. — 1.2; 1.3 Number of…

Primary: Occurrence of Urinary Tract Cancer — 0.73; 1.07; 1.34; 1.52 Events per 1000 patient years — p=0.122

Primary: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) — 7; 6 Participants

Primary: Urinary Tract Infection — 11; 12 UTI

Primary: Urinary Tract Infection After Percutaneous Nephrostomy Procedure — 5; 10 Percutaneous nephrostomy procedure — p=0.548

Primary: Number of Participants Who Were Cured — 120; 130 Participants — p=<0.001

Primary: Resolution of UTI Symptoms 14 Days After Completing Active Antimicrobial Therapy — 111; 122 Participants

Primary: Number of Participant With Urinary Tract Infection — 12; 13 Participants

Primary: Post-operative Urinary Tract Infection — 19; 20 Participants

Primary: The Primary Efficacy Outcome of the Study is Response to Treatment Which Will be Assessed at the End of Therapy. Successful Response to Treatment is Defined as…

Primary: Change in Vaginal Microbiota — 2.75 change in percent relative abundance

Primary: Participants With Clinically-diagnosed and Treated UTI's. — 15; 30 participants

Primary: Changes to the Urinary Microbiota — 3; 2; 1 participants

Primary: Participants With Urine Cultures With Bacteriuria (>100,000 Cfu/ml or >=100,000 Cfu/ml) Plus Pyuria (Any WBC) — 26; 32; 21; 27 participants

Primary: Number of Urine Cultures Collected Out of the Total Number Expected to be Collected. — 81; 74; 85; 73 Urine cultures

Primary: Number of Subjects With Combined Clinical and Microbiologic Response — 70 Participants

Primary: Number of Participants Experiencing Urinary Tract Infection Within 6 Weeks of Surgery — 13; 13 Participants — p=0.97

Primary: Incidence of Urinary Track Infection (UTI) — 62; 71 Participants

Primary: Clinical Validation of Biosensor Assays Used for Pathogen Identification and Antimicrobial Susceptibility Testing in Patients at Risk of Urinary Tract Infections. — 89…

Primary: Urinary Tract Infections — 18; 10 participants

Primary: Ureteral Stent Symptom Questionnaire Score Up to 24 Hours Prior to Stent Insertion — 1.76; 1.84; 2.02; 1.93 score on a scale

Primary: Number of Participants With Elevated Cytokines (Levels of Pro-inflammatory) — 20; 20; 16 Participants

Primary: Incidence of Urinary Tract Infection — 7; 13 participants

Primary: Bacterial Genomic Sequencing — 25; 11; 3; 6 participants

Primary: Patient-reported Symptomatic Response at Day 5 (mMITT Analysis Set): Non-inferiority Hypothesis Test — 276; 276; 103; 124 Participants

Primary: Number of Participants With a Symptomatic Stone Event — 154; 165 Participants

Primary: Change in Urine cAMP Concentration and Urine Osmolality (UOsm) — -2.6; -2.0 fold change in cAMP/UOsm (umol/UOsm)

Primary: Patient-reported Symptomatic Response at Day 5 (mMITT Analysis Set): Non-inferiority Hypothesis Test — 276; 276; 103; 124 Participants

Primary: Time to Subsequent Infection as Defined From Time of Treatment Initiation to Recurrence of UTI — 101; 119 days

Primary: Occurrence of Symptomatic Urinary Tract Infections (UTIs) — 19; 20; 2; 0 participants — p=0.0383